BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3879182)

  • 1. Pharmacokinetics of the trimethoprim-sulphamethoxazole combination in the elderly.
    Varoquaux O; Lajoie D; Gobert C; Cordonnier P; Ducreuzet C; Pays M; Advenier C
    Br J Clin Pharmacol; 1985 Dec; 20(6):575-81. PubMed ID: 3879182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR; Gorham CC; Ericson JF; Smith AL
    Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
    Rieder VJ; Schwartz DE
    Arzneimittelforschung; 1975 Apr; 25(4):656-66. PubMed ID: 1174084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
    Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
    Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients.
    Naber K; Vergin H; Weigand W
    Infection; 1981; 9(5):239-43. PubMed ID: 6975241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Co-trimoxazole concentration in the prostatic fluid of patients with subacute and chronic prostatitis].
    Hofstetter A; Friesen A; Bishop-Freudling GB; Vergin H
    Fortschr Med; 1984 Mar; 102(9):244-6. PubMed ID: 6608482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state pharmacokinetics of sulfamethoxazole and trimethorprim in man after rectal application.
    Liedtke R; Haase W
    Arzneimittelforschung; 1979; 29(2):345-9. PubMed ID: 582148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis.
    Nelson JD; Kusmiesz H; Shelton S
    Rev Infect Dis; 1982; 4(2):546-50. PubMed ID: 6981170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of cotrimoxazole sulphonamide in malnourished (marasmic) infants.
    Bravo IG; Bravo ME; Plate G; Merlez J; Arancibia A
    Pediatr Pharmacol (New York); 1984; 4(3):167-76. PubMed ID: 6436778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg).
    Fass RJ; Prior RB; Perkins RL
    Antimicrob Agents Chemother; 1977 Jul; 12(1):102-6. PubMed ID: 883811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a sulphamethoxazole/trimethoprim formulation in pigs after intravenous administration.
    Nouws JF; Vree TB; Degen M; Mevius D
    Vet Q; 1991 Jul; 13(3):148-54. PubMed ID: 1949541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetic study of four different sulfonamides in combination with trimethoprim in human volunteers.
    Garg SK; Ghosh SS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):23-5. PubMed ID: 3485584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pectin and kaolin on bioavailability of co-trimoxazole suspension.
    Gupta KC; Desai NK; Satoskar RS; Gupta C; Goswami SN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):320-1. PubMed ID: 3497885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lung tissue diffusion of intravenous trimethoprim-sulfamethoxazole combination (author's transl)].
    Morel C; Langeard M; Vergnaud M; Monrocq N
    Pathol Biol (Paris); 1982 Jun; 30(6):380-4. PubMed ID: 7050846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.
    Wright WL; Larking P; Lovell-Smith CJ
    Br J Urol; 1982 Oct; 54(5):550-1. PubMed ID: 6983378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.
    Bergan T; Brodwall EK; Vik-Mo H; Anstad U
    Infection; 1979; 7 Suppl 4():S382-7. PubMed ID: 511352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients.
    Vergin H; Ferber H; Zimmermann I; Neurath GB
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):350-7. PubMed ID: 6975762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.